Continuous Renal Replacement Therapy (CRRT) Market by Product (Disposables (Hemofilters, Bloodlines), Machine, Dialysates, Renal Replacement fluids), Modality (SCUF, CVVH, CVVHD, CVVHDF), Patient (Adult, Pediatrics, Neonates) and Geography (North America, Europe, Asia-Pacific, Middle East and Africa and South America)
The global continuous renal replacement therapy market size is projected to reach USD 1.7 billion by 2026 from USD 1.2 billion in 2021, at a CAGR of 7.3% during the forecast period.
Rise in worldwide prevalence of AKI, growing number of ICU patients with AKI and increasing incidence of sepsis, and growing clinical advantage of CRRT over intermittent blood purification are some of the factors that have supported long-term expansion for Continuous Renal Replacement Therapy (CRRT) Market.
Continuous Renal Replacement Therapy (CRRT) Market is segmented into product, modality, age group and geography.
Product segment is segmented into Dialysates and Replacement Fluids, disposables, hemofilters, bloodline sets & tubes and CRRT systems.
Modality segment is segment is segmented into Continuous venovenous hemofiltration (CVVH), Continuous venovenous hemodiafiltration (CVVHDF), Continuous venovenous haemodialysis (CVVHD) and Slow continuous ultrafiltration (SCUF).
Age group segment is segmented into adults and paediatrics/ neonates.
Geographically, Continuous Renal Replacement Therapy (CRRT) Market is sub segmented into North America, Europe, Asia-Pacific, Middle East and Africa and South America and insights are provided for each region and major countries within the regions
Key players in Continuous Renal Replacement Therapy (CRRT) Market are Baxter International Inc. (US), Fresenius Medical Care AG & Co. KGaA (Germany), NIKKISO CO., LTD. (Japan), B. Braun Melsungen AG (Germany), Asahi Kasei Corporation (Japan), Toray Medical Co., Ltd. (Japan), Infomed SA (Switzerland), Medtronic plc (Ireland), Medica S.p.A. (Italy), Medical Components, Inc. (US), Medites Pharma spol. s.r.o. (Czech Republic), SWS Hemodialysis Care Co., Ltd. (China), Ningbo Tianyi Medical Devices Co., Ltd. (China), Nipro Corporation (Japan), and Anjue Medical Equipment Co., Ltd. (China).
Report Feature |
Descriptions |
---|---|
Market Revenue In 2021 |
USD 1.2 billion |
Growth Rate |
CAGR of 7.3% during the forecasting period, 2021-2028 |
Historical Data |
2018-2019 |
Forecast Years |
2021-2028 |
Base Year |
2020 |
Units Considered |
Revenue in USD billion and CAGR from 2021 to 2028 |
Report Segmentation |
product, modality, age group and geography |
Report Attribute |
Market Revenue Sizing (Global, Regional and Country Level) Company Share Analysis, Market Dynamics, Company Profiling |
Regional Level Scope |
North America, Europe, Asia-Pacific, South America, and Middle East and Africa |
Country Level Scope |
U.S., Japan, Germany, U.K., China, India, Brazil, UAE, South Africa (50+ Countries Across the Globe) |
Companies Profiled |
Baxter International Inc. (US), Fresenius Medical Care AG & Co. KGaA (Germany), NIKKISO CO., LTD. (Japan), B. Braun Melsungen AG (Germany), Asahi Kasei Corporation (Japan), Toray Medical Co., Ltd. (Japan), Infomed SA (Switzerland), Medtronic plc (Ireland), Medica S.p.A. (Italy), Medical Components, Inc. (US), Medites Pharma spol. s.r.o. (Czech Republic), SWS Hemodialysis Care Co., Ltd. (China), Ningbo Tianyi Medical Devices Co., Ltd. (China), Nipro Corporation (Japan), and Anjue Medical Equipment Co., Ltd. (China). |
Available Customization |
In addition to the market data for Continuous Renal Replacement Therapy (CRRT) Market, Delvens offers client-centric report and customized according to the company’s specific demand and requirement. |